Responses
Poster Presentations
Rheumatoid arthritis - non-biologic treatment and small molecules
THU0193 Response To Baricitinib at 4 Weeks Predicts Response at 12 and 24 Weeks in Patients with Rheumatoid Arthritis: Results from Two Phase 3 Studies
Compose a Response to This Article
Other responses
No responses have been published for this article.